Diebold Nixdorf (DBD) Tops Q3 EPS by 45c; Raises FY EPS Guidance, Lowers Revs
Get Alerts DBD Hot Sheet
Price: $72.15 +0.52%
Financial Fact:
Income (loss) from discontinued operations, net of tax: 500K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income (loss) from discontinued operations, net of tax: 500K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q3 EPS of $0.58, $0.45 better than the analyst estimate of $0.13. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.17 billion.
GUIDANCE:
Diebold Nixdorf sees FY2017 EPS of $1.05-$1.15, versus $0.95-$1.15 prior and the consensus of $0.99. Diebold Nixdorf sees FY2017 revenue of ~$4.6 billion, versus ~$4.7-$4.8 billion prior and the consensus of $4.75 billion.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
- Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share